The rapid spread of influenza virus worldwide is driving the demand for the development of efficient influenza vaccine. Increasing clinical trials for new product development by market players
/PRNewswire/ DelveInsight s Influenza Pipeline Insight 2022 report provides comprehensive global coverage of available, marketed, and pipeline influenza.
Data also discussed in context of OVX836 clinical development update presentation at 2022 World Vaccine Congress Osivax, a biopharmaceutical company developing vaccines to protect against highly